Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H1WV
|
||||
Former ID |
DNC010149
|
||||
Drug Name |
Mulberrofuran W
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530464] | ||
Structure |
Download2D MOL |
||||
Formula |
C29H34O4
|
||||
Canonical SMILES |
CC(=CCCC(=CCCC(=CCC1=C(C=C(C=C1C2=CC3=C(O2)C=C(C=C3)O)O<br />)O)C)C)C
|
||||
InChI |
1S/C29H34O4/c1-19(2)7-5-8-20(3)9-6-10-21(4)11-14-25-26(16-24(31)17-27(25)32)29-15-22-12-13-23(30)18-28(22)33-29/h7,9,11-13,15-18,30-32H,5-6,8,10,14H2,1-4H3/b20-9-,21-11-
|
||||
InChIKey |
YUFBSQFJPYHMTK-QUYCRGELSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of Protein tyrosine phosphatase-1B | Target Info | Inhibitor | [530464] | |
KEGG Pathway | Adherens junction | ||||
Insulin signaling pathway | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Cadherin signaling pathway | ||||
Pathway Interaction Database | Insulin Pathway | ||||
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) | |||||
Signaling events mediated by PTP1B | |||||
Calcineurin-regulated NFAT-dependent transcription in lymphocytes | |||||
Signaling events mediated by TCPTP | |||||
IGF1 pathway | |||||
EGF receptor (ErbB1) signaling pathway | |||||
Posttranslational regulation of adherens junction stability and dissassembly | |||||
PDGFR-beta signaling pathway | |||||
N-cadherin signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.